Trinity Biotech (TRIB) Total Debt (2016 - 2021)
Trinity Biotech (TRIB) has disclosed Total Debt for 6 consecutive years, with $31000.0 as the latest value for Q4 2021.
- Quarterly Total Debt changed 0.0% to $31000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $31000.0 through Dec 2021, changed 0.0% year-over-year, with the annual reading at $31000.0 for FY2021, 0.0% changed from the prior year.
- Total Debt hit $31000.0 in Q4 2021 for Trinity Biotech, roughly flat from $31000.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $93.0 million in Q4 2017 to a low of $31000.0 in Q4 2020.
- Historically, Total Debt has averaged $51.3 million across 5 years, with a median of $81.4 million in 2018.
- Biggest five-year swings in Total Debt: grew 0.79% in 2019 and later tumbled 99.96% in 2020.
- Year by year, Total Debt stood at $93.0 million in 2017, then dropped by 12.45% to $81.4 million in 2018, then increased by 0.79% to $82.0 million in 2019, then crashed by 99.96% to $31000.0 in 2020, then changed by 0.0% to $31000.0 in 2021.
- Business Quant data shows Total Debt for TRIB at $31000.0 in Q4 2021, $31000.0 in Q4 2020, and $82.0 million in Q4 2019.